As Rancho BioSciences introduces its new identity, Founder and CEO Julie Bryant shares the story behind the company and the beliefs that shaped it. From the early days of systems biology to today’s era of AI-driven research, Rancho has focused on one mission: helping scientists turn complex biomedical data into structured, reusable information that accelerates discovery.
I learned early in my career that discoveries often go missing, not because we lack ideas, but because we overlook the data sitting right in front of us. That belief has shaped every team I have led and every company I have built. It is also the reason Rancho BioSciences exists today.
Before Rancho, I co-founded GeneGo in 2000 with a concept and a credit card. We bet on systems biology long before it became mainstream. Our pathway platform helped scientists understand complex biology in new ways. When GeneGo joined Thomson Reuters, I carried forward one lesson: when information is organized well, science moves faster and decisions become clearer.
After GeneGo, I spent years traveling to pharmaceutical research sites around the world. I saw brilliant scientists running expensive experiments to answer a single question. But once the experiment was finished, much of the data was discarded—even though it still held significant value. That unused data could have supported additional comparisons, deeper insight, and new ideas. What was missing was structure, time, and expertise. I knew exceptional scientists who could curate and harmonize this information. I also knew that most people did not want to do that work. We loved it. That was the moment Rancho BioSciences began to take shape.
My first hire was the exceptional Tatiana Khasanova, who had also worked with me at GeneGo. Together, we built Rancho around a simple idea. If we turn raw, disconnected biomedical data into high-quality structured information, scientists can discover faster and patients can benefit sooner.
As science evolved, Rancho evolved with it. We began with data curation and became known globally for rigor and quality. In many ways, we were making data FAIR before FAIR had a name. As the volume and variety of life sciences data expanded, we grew into bioinformatics so curated datasets could generate deeper insight. We then added data engineering to support scale, cloud and automation teams to support speed, and data science and machine learning groups to support more advanced analysis.
Across hundreds of projects, the same challenges appear again and again across the life sciences industry. Data scattered across modalities slows discovery. Inconsistent metadata weakens reproducibility. Scientists lose valuable time preparing data instead of exploring ideas. Too often, organizations treat data as a one-time task instead of a reusable asset that can be extended and enriched over time. As AI becomes central to discovery, teams are learning an important lesson: algorithms cannot compensate for poorly prepared data.
Rancho BioSciences exists to solve these problems. We deliver structured, harmonized, reusable datasets and build the systems and workflows that allow organizations to get more value from complex multimodal biomedical data. When the data foundation is strong, everything downstream becomes faster, more reliable, and more impactful.
Today Rancho is a global biomedical data science company working with many of the world's leading pharmaceutical, biotech, and research organizations. Our work spans strategic consulting, data curation and knowledge automation, data engineering, bioinformatics, data science, and AI-enabled data products.
We support research across oncology, immunology, neuroscience, gastrointestinal diseases, and rare conditions. What we do today reflects the evolving needs of the organizations we serve.
Our capabilities have expanded as scientific research has advanced. Organizations needed help scaling data curation, so we built global teams of expert scientists. They needed insights from complex datasets, so we built one of the strongest bioinformatics organizations in the industry. They needed engineering, cloud infrastructure, and automation, so we expanded those capabilities as well. As new research areas emerged—including single-cell biology, spatial biology, and multimodal data—we developed modern biomedical data products and partnerships. Today, as AI becomes central to research, we support responsible frameworks and infrastructure for emerging technologies like Agentic AI. Every step of Rancho’s evolution has been guided by what our clients need to advance science.
As Rancho has grown, so has our identity. Our new brand reflects who we are today: a trusted partner for scientists and R&D teams who need high-quality biomedical data, deep domain expertise, and teams committed to scientific outcomes. Our visual identity represents what we call the Rancho triad:
Scientific Intelligence, Data Mastery, and Applied AI. Together, these strengths allow us to transform complex data into information that scientists can use with confidence.
The Data Foundation Behind Scientific Discovery
Our brand captures our purpose. Rancho BioSciences helps organizations solve complex scientific problems by building the data foundations that discovery depends on. We support the people doing the hard work of science. And we ensure the data behind that work is trustworthy, consistent, reusable, and ready for the future. Great science begins when the data is right. At Rancho, we will always be the team that makes the data right.
Rancho BioSciences helps pharmaceutical, biotech, and research organizations transform complex biomedical data into structured, reusable datasets that accelerate discovery. Explore our capabilities and learn how we help scientists move faster from data to insight.